July 8, 2020July 8, 2020
BMS, Dragonfly Working on Immune System-targeting Therapies for MS

Dragonfly Therapeutics and Bristol Myers Squibb (BMS) announced an expanded partnership focused on discovering and developing treatment candidates for multiple sclerosis (MS) and neuroinflammation targets. ... Read more
July 8, 2020July 8, 2020
Switch from Tysabri to Ocrevus Seen as Safe, Effective in RRMS Patients in Small Study

Switching to Ocrevus (ocrelizumab) within a relatively short period is a safe and effective option for people with relapsing-remitting multiple sclerosis (RRMS) ... Read more
July 7, 2020July 8, 2020
Study: Mavenclad Shows Long-term Effectiveness at Preventing MS Relapses, Disease Progression

Mavenclad (cladribine) prevents relapses and disease progression in more than half of patients with relapsing forms of multiple sclerosis (MS) for at least five ... Read more
July 7, 2020July 7, 2020
Collaborative Project Will Focus on TRPM4 as Potential Therapeutic Target for MS

The German Federal Ministry of Education and Research (BMBF) has granted €1.2 million ($1.35 million) to support a project seeking to characterize the function ... Read more
July 6, 2020July 6, 2020
Here Comes the Sun, and It’s All Too Much

Yup, it’s the annual whinge about what heat does to most of us, this time livened up by a headline that includes two Beatles’ ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

Columns

Social Clips

June 26, 2018July 3, 2018

1st Patient Enrolled in Study of Electrical Stimulation in Treating Brain Injury

News

A first patient has been enrolled in a single-site trial to evaluate the potential of electrical stimulation, called Electroceutical Therapy, in reducing brain injury, Endonovo Therapeutics, the therapy’s developer, announced. Electroceutical Therapy is a non-invasive and wearable electronic device that uses pulsed ... Read more

BMS, Dragonfly Working on Immune System-targeting Therapies for MS

Switch from Tysabri to Ocrevus Seen as Safe, Effective in RRMS Patients in Small Study

Study: Mavenclad Shows Long-term Effectiveness at Preventing MS Relapses, Disease Progression

Collaborative Project Will Focus on TRPM4 as Potential Therapeutic Target for MS

Here Comes the Sun, and It’s All Too Much

Here Comes the Sun, and It’s All Too Much

MS News That Caught My Eye Last Week: Wearable Sensors, COVID-19, Tecfidera

Higher BMI as Teenagers Raises Risk of MS for Men, Study Finds

Tecfidera Safe and Effective in Hispanic/Latino MS Patients, Real-world Data Show

How to Feed Your Soul and Find Positivity Amid MS

Osmotica Amends NDA for Arbaclofen ER to Treat MS Spasticity

Subscribe to our mailing list

Anxiety and Depression Linked to RRMS Relapse Risk, Study Finds

Exposure to DMTs Does Not Increase Risk of Severe COVID-19 in MS Patients, Study Finds

3 Things to Do If You’re Freaked Out by Blood Tests

Study of Temelimab in MS Progression Without Relapse Enrolls 1st Patient

Boosting Cellular Energy at Sites of Myelin Loss May Stop MS Progression

MS News That Caught My Eye Last Week: Mayzent, Hookworm Therapy, Walking and Falling, ADS-5102

Tecfidera Safe and Effective Over Years of Use, RRMS Study Finds

AccessNow Wins Top ‘Novartis Innovation Prize’ for App That Aids Mobility

Updating the Shifting MS-COVID-19 Treatment Equation

Columns

Here Comes the Sun, and It’s All Too Much

MS News That Caught My Eye Last Week: Wearable Sensors, COVID-19, Tecfidera

How to Feed Your Soul and Find Positivity Amid MS

3 Things to Do If You’re Freaked Out by Blood Tests

MS News That Caught My Eye Last Week: Mayzent, Hookworm Therapy, Walking and Falling, ADS-5102

Updating the Shifting MS-COVID-19 Treatment Equation

Actress Selma Blair’s Response to MS Motivates Me

Being Free from Symptom Flares Makes Me Feel Like a Fraud

MS News That Caught My Eye Last Week: Gilenya and COVID-19, Depression, Switching from Tysabri

Beach, Please!

All Quiet on the MS Front

My Review of 2 New MS Apps: icompanion and BelongMS

Need to Know: What Is Nystagmus and How Does It Affect MS Patients?

When You Become the Caregiver, You Must Push Past MS for Love

Social Clips

1st Patient Enrolled in Study of Electrical Stimulation in Treating Brain Injury

BMS, Dragonfly Working on Immune System-targeting Therapies for MS

Switch from Tysabri to Ocrevus Seen as Safe, Effective in RRMS Patients in Small Study

Study: Mavenclad Shows Long-term Effectiveness at Preventing MS Relapses, Disease Progression

Collaborative Project Will Focus on TRPM4 as Potential Therapeutic Target for MS

Here Comes the Sun, and It’s All Too Much

Here Comes the Sun, and It’s All Too Much

MS News That Caught My Eye Last Week: Wearable Sensors, COVID-19, Tecfidera

Higher BMI as Teenagers Raises Risk of MS for Men, Study Finds

Tecfidera Safe and Effective in Hispanic/Latino MS Patients, Real-world Data Show

How to Feed Your Soul and Find Positivity Amid MS

Osmotica Amends NDA for Arbaclofen ER to Treat MS Spasticity

Subscribe to our mailing list

Anxiety and Depression Linked to RRMS Relapse Risk, Study Finds

Exposure to DMTs Does Not Increase Risk of Severe COVID-19 in MS Patients, Study Finds

3 Things to Do If You’re Freaked Out by Blood Tests

Study of Temelimab in MS Progression Without Relapse Enrolls 1st Patient

Boosting Cellular Energy at Sites of Myelin Loss May Stop MS Progression

MS News That Caught My Eye Last Week: Mayzent, Hookworm Therapy, Walking and Falling, ADS-5102

Tecfidera Safe and Effective Over Years of Use, RRMS Study Finds

AccessNow Wins Top ‘Novartis Innovation Prize’ for App That Aids Mobility

A Morning With No Opera but Enough for a Small Choir!

Updating the Shifting MS-COVID-19 Treatment Equation

Here Comes the Sun, and It’s All Too Much

MS News That Caught My Eye Last Week: Wearable Sensors, COVID-19, Tecfidera

How to Feed Your Soul and Find Positivity Amid MS

3 Things to Do If You’re Freaked Out by Blood Tests

MS News That Caught My Eye Last Week: Mayzent, Hookworm Therapy, Walking and Falling, ADS-5102

A Morning With No Opera but Enough for a Small Choir!

Updating the Shifting MS-COVID-19 Treatment Equation

Actress Selma Blair’s Response to MS Motivates Me

Being Free from Symptom Flares Makes Me Feel Like a Fraud

MS News That Caught My Eye Last Week: Gilenya and COVID-19, Depression, Switching from Tysabri

Beach, Please!

All Quiet on the MS Front

My Review of 2 New MS Apps: icompanion and BelongMS

Need to Know: What Is Nystagmus and How Does It Affect MS Patients?

When You Become the Caregiver, You Must Push Past MS for Love

10 Mobile Apps for Better Living With MS

4 Ways Ocrevus Can Improve Your Life

Ocrevus Treatment and Side Effects: What’s Important to Know

4 Ways Ocrevus Can Improve Your Life

5 Things to Know About the New MS Drug Ocrevus

9 Drug Approvals That Changed The Future of Medicine

5 Things to Know About the New MS Drug Ocrevus

9 Approved MS Therapies You Should Know About

Ann Romney’s Fight with Multiple Sclerosis

9 Approved MS Therapies You Should Know About

10 Relapsing-Remitting Multiple Sclerosis (RRMS) Therapies

#CMSC16 – MS and Yoga: Author and Instructor Says Ancient Discipline Can Help Patients in Many Ways

#CMSC16 – Country Artist Clay Walker to MS Patients: You’re Going to Be OK

9 Approved MS Therapies You Should Know About

Mike Nace, Editor-in-Chief of Multiple Sclerosis News Today, Reviews Day 1 at #ECTRIMS2015

1st Patient Enrolled in Study of Electrical Stimulation in Treating Brain Injury